Financial Disclosure

Pensacola, Fla. – October 01, 2026 -- Baptist Health Care and PAM Health have restructured their joint venture, adding 40 acute care beds at Baptist Hospital and building a freestanding 60-bed inpatient rehabilitation hospital at Baptist Medical Park – Nine Mile, pushing Baptist Hospital's total bed count from 279 to 319.

Revised plan scraps original 40-bed rehab unit for larger freestanding facility

The updated agreement replaces a plan first announced in early 2025, which called for a 40-bed inpatient rehabilitation hospital housed within the Henderson Health Center on the Baptist Hospital campus. Under the new structure, PAM Health and Baptist Health Care will instead construct a standalone 60-bed rehabilitation hospital at the Nine Mile campus, freeing the Henderson Health Center space for conversion into a 40-bed acute care unit.

Toronto – October 01, 2026 -- Mayfair Gold Corp. (TSXV: MFG) (NYSE American: MINE) has signed a subscription agreement for a C$10 million strategic equity investment from Macquarie Bank Limited and a non-binding term sheet for a proposed C$300 million project finance facility, bringing the total financing package for its Fenn-Gib Gold Project to up to C$310 million.

Macquarie buys in at a 10% premium to fund Fenn-Gib's Timmins development

Macquarie will acquire Mayfair common shares at C$4.26 each, a 10% premium to the 5-day volume-weighted average price through September 30, 2026, subject to TSX Venture Exchange approval. The proposed C$300 million facility, which includes up to C$20 million of capitalized interest, would cover the majority of the C$450 million initial development capital outlined in Mayfair's 2026 Pre-Feasibility Study for Fenn-Gib, located in the Timmins region of Northern Ontario.

Palo Alto, Calif. -- October 01, 2026 -- Armadin, an AI-native cybersecurity company, has raised $255.5 million in a Series B round that pushes its valuation above $2.5 billion just seven months after launching from stealth. The round was co-led by Andreessen Horowitz (a16z) and Accel, with new investors Bain Capital Ventures and Redpoint joining. Existing backers 8VC, Ballistic Ventures, Google Ventures, In-Q-Tel, Kleiner Perkins, and Menlo Ventures also returned, lifting Armadin's total funding to $445 million.

Birkirkara – October 01, 2026 -- Gentoo Media Inc. has called an Extraordinary General Meeting of Shareholders for 2 November 2026 in Stockholm to approve a capital structure overhaul that would pave the way for a directed share issue fully underwritten by three of its largest shareholders.

Board seeks to raise authorized Common Stock to 250 million shares and create a new Class Z class

The Board of Directors is proposing a Third Amended and Restated Certificate of Incorporation that would lift authorized Common Stock from 200,000,000 to 250,000,000 shares, $0.001 par value each, while creating an additional class of 100,000,000 shares designated Class Z Common Stock. As of the notice date, Gentoo Media had 134,707,976 shares of Common Stock outstanding, each carrying one vote.

New York – – October 01, 2026 -- Nuveen has completed its acquisition of Schroders, creating a combined asset and wealth manager with $2.6 trillion in assets under management as of June 30, 2026.

Combined firm claims top-ten rank across three asset classes globally

The merged entity holds a top-ten global position in active equities, active fixed income and private markets, based on year-end 2025 data from Preqin, P&I, eVestment and company reports. It operates in more than 40 markets with significant presence across the US, UK, Europe and Asia-Pacific.

TIAA backs deal as parent shareholder

TIAA CEO Thasunda Brown Duckett said the acquisition strengthens investment capabilities feeding TIAA's retirement and annuity products. TIAA paid out more than $6.17 billion in annuity income to retired clients in 2025.

Stockholm – October 01, 2026 -- SciBase Holding AB has closed its rights issue fully subscribed, raising approximately SEK 57.5 million before issue costs to fund continued commercialisation of its Nevisense melanoma-diagnostics platform in the United States.

Shareholders cover nearly three-quarters of the offering

The subscription period, which ran through 29 September 2026, saw 2,681,085 shares subscribed with the support of subscription rights, equal to roughly SEK 40.2 million, or 69.9 percent of the issue. An additional 133,116 shares were subscribed without subscription rights, adding SEK 2.0 million, or 3.5 percent. In total, 2,814,201 shares were subscribed with and without rights, covering approximately SEK 42.2 million, or 73.4 percent of the SEK 57.5 million target.

Birkirkara, Malta – October 01, 2026 -- Gentoo Media Inc. has locked in commitments worth EUR 100 million to refinance its EUR 91.5 million senior secured bonds maturing 18 December 2026, combining a new EUR 50 million term loan with a fully underwritten EUR 50 million share issue.

STOCKHOLM – October 01, 2026 -- Ericsson (NASDAQ: ERIC) will publish its third-quarter 2026 financial report at approximately 7:00 AM CEST on October 15, 2026, the Stockholm-based telecom equipment maker confirmed.

Ericsson sets October 15 release date with full PDF financial tables

The company will issue a press release with the complete financial report attached, including detailed tables in PDF format. The report will be posted on Ericsson's investor relations website immediately following the press release.

CEO Per Narvinger and CFO Lars Sandström to field analyst questions at 9:00 AM CEST webcast

President and CEO Per Narvinger and CFO Lars Sandström will present the results and take live questions during a video webcast scheduled for 9:00 AM CEST, equivalent to 8:00 AM BST in London and 3:00 AM EDT in New York. Journalists and analysts can submit questions via a dedicated dial-in line during the session.

Madrid – October 01, 2026 -- Fresenius SE & Co. KGaA has completed the acquisition of the remaining 45% stake in mAbxience from Insud Pharma, giving the German healthcare group full ownership of the Spanish biosimilars manufacturer.

Fresenius consolidates control after four-year partnership

Fresenius first acquired a 55% majority stake in mAbxience in August 2022 and has consolidated the business since then. The deal closes out that ownership structure, placing mAbxience's biosimilars platform entirely within Fresenius Kabi's Biopharma division, which spans development, manufacturing and commercialization.

Sydney – October 01, 2026 -- IMG (International Medical Group) has completed its acquisition of World Nomads, a deal first announced in February 2026, extending its travel insurance distribution network across seven major markets.

Deal expands IMG's footprint into US, UK, EU, Australia, New Zealand, Brazil and Canada

The combined entity will now distribute travel protection and assistance products across these markets, reaching travelers from more than 100 countries who previously relied on World Nomads' specialized adventure travel coverage.